Press What’s news at AbelsonTaylor Group
Select category
AbelsonTaylor Group Named PM360 Trailblazer Finalists in Nine Categories

AbelsonTaylor Group has been named a finalist in nine categories of the 2023 Trailblazer Awards.
The finalists are:
- Professional Website/Online Initiative: CIMERLI Website “Similar but Uniquely Different” (Coherus BioSciences and AT Nutrient)
- Professional Campaign: CIMERLI Campaign “Similar but Uniquely Different” (Coherus BioSciences and AT Nutrient)
- Consumer Website/Online Initiative: HUMATE-P Website “Anna’s Timeline”(CSL Behring and AbelsonTaylor)
- Direct to Patient Campaign: HUMATE-P DTP Campaign “Anna’s Timeline” (CSL Behring and AbelsonTaylor)
- Social Media Campaign: HUMATE-P Social Media “Anna’s Timeline” (CSL Behring and AbelsonTaylor)
- Direct to Patient Campaign: HEMGENIX DTP Campaign “A New World” (CSL Behring and AbelsonTaylor)
- Sales Aid: HEMGENIX Sales Aid “A New World” (CSL Behring and AbelsonTaylor)
- Sales Aid: INGREZZA “Best of Both Worlds” Professional Sales Aid (Neurocrine Biosciences and AbelsonTaylor)
- Marketing Team of the Year: Seres Therapeutics and Nestle Health Science Marketing Teams (Seres Therapeutics, Nestle Health Science and Agency Partner: AbelsonTaylor)
“We are so proud that many of our client campaigns have been recognized as finalists in these prestigious Trailblazer Awards,” said AbelsonTaylor Group President Jeff Berg. “These entries exemplify the collaboration by our teams and partners to effectively inform HCPs and compassionately educate consumers about products that can improve their health and quality of life.”
Since 2009, the PM360 Trailblazer Awards, sponsored by medical marketing publication PM360, have recognized outstanding achievement and innovation in healthcare marketing. Each year, nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts. Winning initiatives were selected for their ability to stand out in the complex, ever-changing healthcare environment, and were judged on their ability to overcome challenges; the skill, innovation, and quality of planning and execution; and the effectiveness of the work. A total of 88 finalists were chosen in the 18 Initiative categories.
“Developing marketing initiatives within the life sciences always requires striking a unique balance between being innovative but within regulatory confines, delivering a personally relevant experience but without being intrusive, and relaying all of the important information but in a way the audience can still comprehend,” says Anna Stashower, CEO and Publisher of PM360. “The finalists accomplished all of that thanks to creative engagement methods, eye-catching images, immersive experiences, and more. But more importantly, they also showed an emphatic approach that took the time to understand their audiences so messages were delivered with the care and attention patients and providers deserve.”
Winners will be announced during a gala celebration at Gotham Hall in New York City on Tuesday, October 3.
Media Contact:
Recent Posts
Pharma brands are struggling to keep the attention of digitally savvy HCPs
Lynnette Hunter, EVP, Director of Client Services, talks to MM+M’s Jack O’Brien about what a digitally savvy HCP is in...
Read Press Read more Pharma brands are struggling to keep the attention of digitally savvy HCPsSix steps to navigating the future of pharmaceutical advertising
Terence Prudhomme, Senior Media Director for AT Activate, discusses six steps to optimizing the evolving media landscape for pharma advertisers to communicate...
Read Press Read more Six steps to navigating the future of pharmaceutical advertisingHow will medical marketing’s DE&I efforts fare in 2025?
Antonio Rivera, director of engagement at AbelsonTaylor Group, discusses how as AI becomes more embedded in healthcare and marketing, it...
In the News Read more How will medical marketing’s DE&I efforts fare in 2025?Connect with us
Find out what's top of mind for the people reimagining health and wellness advertising.